Articles in this set
The online version of this special report is sponsored by Eurima.
Eurima is the European Insulation Manufacturers Association and represents the interests of all major mineral wool insulation producers throughout Europe.
Eurima was established in 1959 to promote improved standards and regulations for the use of insulation materials. More recently, it has developed to reflect the growing environmental concerns of society.
Eurima members employ over 21,000 people across Europe with the installation of insulation products accounting for an estimated 300,000 man-years.
Mineral wool insulation products are used in residential and commercial buildings as well as industrial facilities. Glass and stone wool insulation secure a high level of comfort, low energy costs and minimised CO2 emissions. Mineral wool insulation prevents heat loss through roofs, walls, floors, pipes and boilers, reduces noise pollution and protects homes and industrial facilities from the risk of fire.
To find out more about how mineral wool contributes to energy efficiency and sustainability in buildings go to: www.eurima.org
As scientific and business interests from the developed world scour the earth in pursuit of natural materials that might be put to economic use, the question that goes with them is: what benefit will there be to the people of the land where something useful is found and extracted?
In November 2010, there was one thorny issue that kept international negotiations about the UN Convention on Biological Diversity going on into the early hours of the morning. That issue was access and benefit sharing (ABS) and the resulting Nagoya Protocol, in which signatory countries to the UN Convention agreed to set a target for 17% of the earth to be covered by protected zones, would not have been possible without some sort of agreement on ABS.
Developing countries said they would not agree to a target unless there was an agreement to share the benefits of natural resources with indigenous peoples. They also insisted that these rules should retroactively cover all years from the convention's establishment in 1993, but this demand was rejected by the developed countries. Companies in developed countries, especially in the pharmaceutical sector, felt such rules would be too cumbersome.
A compromise eventually emerged: the developing countries dropped their insistence on retroactive credit, and the developed countries agreed to set rules on how access to natural resources could be gained and how the profits derived from them should be shared. Countries will have to transpose the ABS requirements into national law, and companies will have to reimburse indigenous people for natural resources extracted in their territory.
But, significantly, the United States, home to the world's largest pharmaceutical sector and the centre of pharmaceutical research, is not a signatory to either the convention or the protocol. So American companies will not have to share the benefits of extraction, but companies from the 193 countries that are signatories to the convention will have to do so.
Most viewed in Environment
British MEPs say the voluntary label goes against Commission promise to reduce EU red tape
There are currently more than 12,000 non-native species in Europe.
The Southern United States have a “troubling history of land degradation” too.
The EU's transparency in an international forum.
There is no conclusive evidence that neonicotinoids harm bees.